-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by extracellular deposition of β-amyloid and intracellular accumulation of phosphorylated tau protein
.
AD is the most common cause of dementia in the elderly.
The incidence of people over 65 years old is about 1.
Early-onset AD is usually caused by mutations in APP, PSEN1 or PSEN2, while late-onset AD (LOAD) is the most common form of AD, showing more complex genetic mechanisms
.
The apolipoprotein ε4 allele (APOE4) is the only common high-risk genetic variant associated with LOAD.
Previous large-scale genome-wide association studies ( GWAS s) have found dozens of low-impact loci, which indicates that LOAD A large part of the genetic component of the disease remains unexplained
.
GWAS
Rare variants, structural variants and genetic interactions are possible reasons for the genetic loss of complex diseases
.
Previous studies have identified rare coding variants of SORL1 and ABCA7, which can affect APP processing
.
The single nucleotide polymorphisms (SNPs) found in genome-wide association studies can only explain part of the inheritance of Alzheimer's disease (AD)
.
Penetrance is considered to be one of the main reasons for the "lost heredity" of AD
.
In this way, Hui Wang and others of Huazhong Agricultural University used three popular methods to carry out genome-wide penetrance screening for the clinical diagnosis of AD (N = 10,389)
.
The subsequent analysis is to eliminate false associations caused by possible confounding factors
.
diagnosis
Then, the co-expression of candidate gene interactions in the brains of AD patients was examined, and their association with the intermediate phenotype of AD was analyzed
.
In addition, a new method has been developed to compile the apparent risk factors into an apparent risk score (ERS) based on multi-factor dimensionality reduction
.
Two independent data sets were used to evaluate the feasibility of ERS in AD risk prediction
.
They found interactions between two candidate genes with PFDR<0.
05 (RAMP3-SEMA3A and NSMCE1-DGKE/C17orf67) and five other genes with PFDR<0.
1
The co-expression of the discovered interactions supports the biological interactions that may exist behind the observed statistical significance
.
In addition, they found that ERSs can identify high-risk individuals with early-onset AD
.
The combined risk score of SNPs and SNP-SNP interaction showed a slight but stable AUC in predicting the clinical status of AD
.
The important significance of this research lies in the discovery: Through the epigenetic analysis of the whole genome, new genetic interactions that may be involved in AD can be determined; ERS can be used as an indicator of AD genetic risk
.
Through genome-wide epigenetic analysis, new genetic interactions that may be involved in AD can be determined; ERS can be used as an indicator of AD genetic risk
.
Original source:
Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction.
Alz Res Therapy.
Leave a message here